Clinical Trials

500 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Phase 1/2 Unknown

314 enrolled

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT05860374 2023-05-16

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

20 enrolled

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Carcinoma, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT04697446 2021-08-10

External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC

279 enrolled

Head & NeckThoracic

Bronchial Diseases, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03634826 2020-06-26

MEDAL

200 enrolled

Carcinoma, Lung Neoplasms

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

40 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03301961 2020-02-05

Multiplex Analysis of Circulating Tumor DNA

400 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT02833467 2019-08-28

Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA

45 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

NCT02605811 2019-03-28

Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer

426 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Small Cell Lung Carcinoma

NCT03780283 2018-12-21

Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC

30 enrolled

Carcinoma, Lung Neoplasms, Small Cell Lung Carcinoma

NCT03765775 2018-12-06

Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative

20 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03664843 2018-11-13

Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients

120 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02433574 2018-07-17

LINNEARRE-I

Phase NA Unknown

20 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02696525 2018-05-21

Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients

145 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02303353 2017-02-24

Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy

BreastGastrointestinalGynecologicPlasma cellThoracic

2,000 enrolled

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Plasmacytoma, Rectal Neoplasms, Stomach Neoplasms

NCT02907606 2016-09-20

Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study

45 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00908336 2009-05-25

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

70 enrolled

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00905983 2009-05-21

Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients

48 enrolled